Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

UK in vitro fertilisation (IVF) team plans to screen for cancer

This article was originally published in Clinica

Executive Summary

The in vitro fertilisation unit at London's Hammersmith Hospital is about to start screening test tube embryos for cancer genes. The group, led by Professor Robert Winston, will use PCR to look for APC mutations in cells taken from three-day-old embryos. Prof Winston acknowledges the ethical problems of genetic selection but argues that pre-implantation screening is better than abortion following amniocentesis.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT093779

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel